ClinicalTrials.Veeva

Menu

Predictors of Myasthenia Gravis Outcome Following Thoracoscopic Thymectomy: Comparative Study Between Thymomatous and Non-Thymomatous Patients

T

Tanta University

Status

Completed

Conditions

Predictor
Myasthenia Gravis
Non-Thymomatous
Thoracoscopic Thymectomy
Thymomatous

Treatments

Other: Data collection

Study type

Observational

Funder types

Other

Identifiers

NCT07319689
36264PR13103/10/25

Details and patient eligibility

About

This study aimed to assess and compare predictors of outcome in patients with thymomatous and non-thymomatous MG undergoing Thoracoscopic thymectomy.

Full description

Myasthenia Gravis (MG) is a chronic autoimmune neuromuscular disorder characterized by fluctuating muscle weakness resulting from antibodies that target acetylcholine receptors or associated proteins at the neuromuscular junction.

Thoracoscopic thymectomy becomes more prominent than traditional transsternal thymectomy due to fewer perioperative complications with shorter hospital stays and more favorable long-term outcomes.

Prognostic outcomes following thoracoscopic thymectomy can vary significantly between non-thymomatous and thymomatous MG, necessitating a thorough investigation of these differences.

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Both sexes.
  • Confirmed diagnosis of Myasthenia Gravis (MG).
  • Underwent Thoracoscopic thymectomy.
  • Availability of complete preoperative and postoperative records, including imaging and histopathology.
  • Minimum follow-up of 9 months post-surgery.

Exclusion criteria

  • Patients who underwent thymectomy for indications other than MG.
  • Incomplete medical records or loss to follow-up before outcome assessment.
  • Patients with concomitant neuromuscular disorders other than MG

Trial design

100 participants in 2 patient groups

Thymomatous Myasthenia Gravis group
Description:
Thymomatous myasthenia gravis (patients with histologically confirmed thymoma).
Treatment:
Other: Data collection
Non-thymomatous Myasthenia Gravis group
Description:
Non-thymomatous myasthenia gravis (patients with thymic hyperplasia or normal/ involuted thymus).
Treatment:
Other: Data collection

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems